SCHEMBL14927102

SCHEMBL14927102

Cc1cc2cc(-c3cccc(-c4cccc(C(C)(C)C)c4)c3)nc(C=O)c2cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.40
▸ CTSS P25774 1/20 0.38
▸ CTSK P43235 1/20 0.38
▸ RXRB P28702 3/20 0.37
▸ RXRA P19793 2/20 0.37
▸ ALDH1A1 P00352 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ LMNA P02545 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CYP26A1 O43174 1/20 0.33
▸ CYP26B1 Q9NR63 1/20 0.33
▸ CTSA P10619 1/20 0.32
▸ TMEM97 Q5BJF2 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ KDM1A O60341 1/20 0.32
▸ PTGDR Q13258 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14927110 0.97 CTSS (0.39) KIF11CTSSCTSKRXRBRXRA
SCHEMBL14927098 0.92 ALDH1A1 (0.42) KIF11RXRBRXRAALDH1A1MAPT
SCHEMBL14927106 0.86 MAPT (0.40) ALDH1A1MAPTLMNAKDM4EMEN1
SCHEMBL12072031 0.85 RAC1 (0.44) KIF11CTSSCTSKRXRBRXRA
SCHEMBL14927101 0.84 KIF11 (0.46) KIF11CTSSCTSKRXRBRXRA
SCHEMBL9984197 0.82 RAC1 (0.45) KIF11CTSSCTSKALDH1A1MAPT
SCHEMBL14927109 0.82 KIF11 (0.45) KIF11CTSSCTSKRXRBRXRA
SCHEMBL14927103 0.78 KIF11 (0.40) KIF11CTSSCTSKRXRBRXRA
SCHEMBL14927095 0.77 MAPT (0.43) KIF11CTSSCTSKRXRBRXRA
SCHEMBL9986822 0.77 RAC1 (0.43) ALDH1A1MAPTLMNAKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 KIF11 4094/4885CTSS 1995/4885CTSK 2530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback